NCT00325221View on ClinicalTrials.gov

Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM)

NACompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

January 31, 2012

Study Completion Date

October 31, 2012

Conditions
ArrhythmiaQuality of Life
Interventions
DEVICE

HM on

Home Monitoring activated after implantation

DEVICE

HM Off

Home Monitoring activated 9 months after implantation

Trial Locations (7)

1140

Hanusch-Krankenhaus, Vienna

4910

Krankenhaus der Barmherzigen Schwestern Ried, Ried

90491

Krankenhaus Martha-Maria Nürnberg, Nuremberg

91054

Universitätsklinikum Erlangen, Erlangen

97080

Universitätsklinikum Würzburg, Würzburg

06869

Herzzentrum Coswig, Coswig

Unknown

Universitätsklinikum, Zurich

All Listed Sponsors
lead

Biotronik SE & Co. KG

INDUSTRY

NCT00325221 - Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM) | Biotech Hunter | Biotech Hunter